Donaldson Capital Management’s Novartis NVS Stock Holding History

Donaldson Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,906	Closed	-$239K	–	149
2015 Q3	$239K	Hold	2,906	–	–	0.04%	126
2015 Q2	$256K	Hold	2,906	–	–	0.04%	123
2015 Q1	$257K	Hold	2,906	–	–	0.04%	120
2014 Q4	$241K	Buy	+2,906	New	+$241K	0.04%	128

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Donaldson Capital Management's NVS Position: Q4 2015 in Review

Donaldson Capital Management sold out of Novartis (NVS) in Q4 2015, closing a stake of 2,906 shares — an estimated $239K sold.

Donaldson Capital Management first reported a position in NVS in Q4 2014 and held it in 4 quarters. The position peaked at $257K in Q1 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

Donaldson Capital Management reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
Donaldson Capital Management sold 2,906 Novartis shares in Q4 2015, an estimated $239K.
Donaldson Capital Management first reported a position in Novartis in Q4 2014 and held it in 4 quarters.
Donaldson Capital Management's Novartis position peaked at $257K in Q1 2015.
926 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on Donaldson Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.